Roivant Sciences Ltd.

NASDAQ:ROIV

11.07 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income 4,231.206-1,115.463-924.116-900.233-519.394
Depreciation & Amortization 22.03618.8575.93200
Deferred Income Tax 00000
Stock Based Compensation 199.627217.781564.95684.9580
Change In Working Capital 19.0356.34515.71971.93815.296
Accounts Receivables 00000
Inventory 00000
Accounts Payables 22.6844.35915.4033.7526.598
Other Working Capital -3.6491.9860.31668.1868.698
Other Non Cash Items -5,237.17229.087-340.22191.199-257.734
Operating Cash Flow -765.268-843.393-677.729-552.138-761.832
Investing Activities:
Investments In Property Plant And Equipment -1.382-12.69-17.436-5.806-4.916
Acquisitions Net -36.983107.855-0.03901,771.691
Purchases Of Investments 0000-68.376
Sales Maturities Of Investments 00320.17016.44
Other Investing Activites 5,241.988-139.4340.6-25.896-20.049
Investing Cash Flow 5,203.623-44.269303.295-31.7021,694.79
Financing Activities:
Debt Repayment -30.705129.75514.810-32.063
Common Stock Issued 438.555379.7080455.7561,354.21
Common Stock Repurchased 0000-1,188.465
Dividends Paid -60000
Other Financing Activities 17.514-10.001291.9820.50883.481
Financing Cash Flow 419.364499.462306.792456.264217.163
Other Information:
Effect Of Forex Changes On Cash 0.6166.281000
Net Change In Cash 4,858.335-381.919-67.642-127.5760
Cash At End Of Period 6,550.451,692.1152,074.0342,141.6762,185.482